• Ticker

    Advertisement Find a Broker - Visit the DailyFinance Broker Center
DJIA 12,454.83 -74.92 -0.60%
NASDAQ 2,837.53 -1.85 -0.07%
S&P 500 1,317.82 -2.86 -0.22%

$30.26 $0.27 (0.90%)

REAL-TIME: Last trade at

Dr. Reddy's Laboratories

NYSE:RDY

Jump to this page for:

Related Resources

Dr. Reddy's Laboratories Should Continue To Gain Market Share In Lucrative Markets

5/25/2012 by Seeking Alpha

Genpact: To Provide Finance, Accounting Services To Dr Reddy's

5/22/2012 by Smart Money

The Zacks Analyst Blog Highlights: Mylan, Bristol-Myers Squibb, Sanofi, Teva Pharmaceuticals and Dr.

5/22/2012 by Nasdaq

RDY Adds to Generic Portfolio - Analyst Blog

5/21/2012 by Nasdaq

Generic Launches Continue at Mylan - Analyst Blog

5/21/2012 by Nasdaq

Bristol-Myers Squibb's Thud Heard Round the World

5/20/2012 by DailyFinance

Dr. Reddy's Launches Plavix' Generic - Analyst Blog

5/18/2012 by Nasdaq

UPDATE:FDA Approves Generic Versions Of Blood-Thinning Drug Plavix

5/17/2012 by Smart Money

Dr. Reddy's Laboratories Misses Where It Counts

5/15/2012 by DailyFinance

Generics Drive Dr. Reddy's - Analyst Blog

5/14/2012 by Nasdaq

Dr Reddy's Laboratories 4Q Net Profit Rises 2.7%, Misses View

5/11/2012 by Smart Money

UPDATE: Dr Reddy's Jan-March Net Grows 2.7%; Misses View On One-Time Charge

5/11/2012 by Smart Money

Mixed Quarter from Teva - Analyst Blog

5/10/2012 by Nasdaq

How High Can Pfizer Fly?

4/26/2012 by DailyFinance

Bombay Stock Exchange Replaces DLF With Dr Reddy's Labs In 30-Share Sensex

4/23/2012 by Smart Money

CORRECT: Bombay Stock Exchange To Replace DLF With Dr Reddy's Labs In 30-Share Sensex

4/23/2012 by Smart Money

The Zacks Analyst Blog Highlights: AstraZeneca plc, Mylan, Teva Pharmaceuticals, Dr Reddy's Laborato

4/3/2012 by Nasdaq

12 Healthcare Dividend Stocks With Gaining Earnings Momentum

4/2/2012 by Trefis

AZN Drug Gets Positive Ruling in US - Analyst Blog

4/2/2012 by Nasdaq

Positive Data on Lilly Psoriasis Drug - Analyst Blog

4/2/2012 by Nasdaq

US Court Rejects AstraZeneca's Case - Analyst Blog

3/30/2012 by Nasdaq

Three Indian Drug Makers Rush To Launch Copy Of AstraZeneca's Seroquel In US

3/28/2012 by Smart Money

Dr Reddy's: US FDA To Inspect Mexico Facility In Last Week Of March

3/20/2012 by Smart Money

Dr. Reddy's Launches Geodon Generic - Analyst Blog

3/14/2012 by Nasdaq

India's Dr. Reddy's Launches Ziprasidone Capsules After US FDA Approves

3/3/2012 by Smart Money

7 Hot Indian Stocks

2/8/2012 by Minyanville

A Smarter Way to Invest in Emerging Markets: Dividends

2/7/2012 by DailyFinance

Dr. Reddy's Laboratories Beats Analyst Estimates on EPS

2/6/2012 by DailyFinance

Dr Reddy's Laboratories 3Q Net Profit Soars 88%, Beats Estimates

2/3/2012 by Smart Money

UPDATE: Dr Reddy's Laboratories 3Q Net Profit Soars 88%; Tops View

2/3/2012 by Smart Money

Dr Reddy's: Resolved US FDA Issue Over Promotion Of Generic Anticlotting Injection

1/27/2012 by Smart Money

Medicines Co. Settles with APP - Analyst Blog

1/24/2012 by Nasdaq

Zacks #5 Rank Additions for Monday - Tale of the Tape

1/23/2012 by Nasdaq

Zacks #5 Rank Additions for Thursday - Tale of the Tape

1/19/2012 by Nasdaq

The Zacks Analyst Blog Highlights: Teva Pharmaceuticals, Mylan, Watson Pharma, Dr. Reddy's and Novar

12/30/2011 by Nasdaq

Dr Reddy's Launches Medicines For Pain, Itchy Skin In India

12/29/2011 by Smart Money

IsoRay's GliaSite Gets Final Nod - Analyst Blog

11/28/2011 by Nasdaq

Pozen Inks $75 Million Royalty Deal for Treximet

11/26/2011 by DailyFinance

Workers End Strike At Dr Reddy's Laboratories South India Plant

11/20/2011 by Smart Money

Dr Reddy's Asks Local Authorities To Help Resolve Labor Problems

11/15/2011 by Smart Money
See More Articles...